Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.
about
Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow-Review of Published LiteratureAllogeneic bone marrow transplantation compared to peripheral blood stem cell transplantation for the treatment of hematologic malignancies: a meta-analysis based on time-to-event data from randomized controlled trials.Sleep disruption in hematopoietic cell transplantation recipients: prevalence, severity, and clinical managementIntra-Bone Marrow Transplantation of Endosteal Bone Marrow Cells Facilitates Allogeneic Hematopoietic and Stromal Cells Engraftment Dependent on Early Expression of CXCL-12.Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.Quantification of biological variation in blood-based therapy--a summary of a meta-analysis to inform manufacturing in the clinic.Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review.G-CSF-primed BM for allogeneic SCT: revisited.Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation.The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation
P2860
Q26749454-D53D2DFE-0FEC-4AED-94DB-DBC946D07424Q33971524-D65AF555-DEB9-419E-81C9-77E471F507F9Q34175300-1BD855B4-00A3-4CBB-8EE3-F0934B8BA711Q36106898-4623DAAC-1F02-441D-9E85-C4854B87924AQ36687119-1CBE6637-A36E-475D-893F-8FA7DE16D17EQ37243360-EC558A9F-536F-48E0-A157-D39C085554A6Q37772229-8E9D8509-5192-49F2-9F21-344CF8DBCC33Q38366631-885EDB28-D1CB-4626-B2F5-EB86A6AC112AQ45716180-ED395713-88FB-4E9B-B116-03D06550FA68Q55713170-A35B2B6D-5282-43FC-BD94-8E5FE3E3B276Q57515082-992A893C-151A-41A0-892F-7A1E5CD0ADD5
P2860
Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is mobilized peripheral blood ...... donors? A case-control study.
@en
Is mobilized peripheral blood ...... donors? A case-control study.
@nl
type
label
Is mobilized peripheral blood ...... donors? A case-control study.
@en
Is mobilized peripheral blood ...... donors? A case-control study.
@nl
prefLabel
Is mobilized peripheral blood ...... donors? A case-control study.
@en
Is mobilized peripheral blood ...... donors? A case-control study.
@nl
P2093
P2860
P50
P1433
P1476
Is mobilized peripheral blood ...... g donors? A case-control study
@en
P2093
Antonio Jiménez-Velasco
Arturo Iriondo
Carlos Solano
Carlos Vallejo
Carmen Martín
David Serrano
Dolores Caballero
Enric Carreras
Ildefonso Espigado
Jose B Nieto
P2860
P304
P356
10.3324/HAEMATOL.2009.006924
P577
2009-09-01T00:00:00Z